Mechanisms of Mitochondrial Dysfunction in Alzheimer’s Disease
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Mitochondria are the primary source for energy generation in the cell, which manifests itself in the form of the adenosine triphosphate (ATP). Nicotinamide dinucleotide (NADH) molecules are the first to enter the so-called electron transport chain or ETC of the mitochondria. The ETC represents a chain of reducing agents organized into four major protein-metal complexes (I-IV) that utilize the flow of electrons to drive the production of ATP. An additional integral protein that is related to oxidative phosphorylation is ATP synthase, referred to as complex V. Complex V carries out ATP synthesis as a result of the electron flow through the ETC. The coupling of electron flow from NADH to molecular oxygen to the production of ATP represents a process known as oxidative phosphorylation. In this review, we describe mainly the bioenergetic properties of mitochondria, such as those found in the ETC that may be altered in Alzheimer's disease (AD). Increasing evidence points to several mitochondrial functions that are affected in AD. Furthermore, it is becoming apparent that mitochondria are a potential target for treatment in early-stage AD. With growing interest in the mitochondria as a target for AD, it has been hypothesized that deficit in this organelle may be at the heart of the progression of AD itself. The role of mitochondria in AD may be significant and is emerging as a main area of AD research.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“including aberrant mitochondrial dynamics and structure [238]”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [238]
Citations
Cites
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455 · cited 1×
“Several facets of mitochondrial dynamics are also dysfunctional in early-stage AD [27], including a disruption in the balance between mitochondrial fusion and fission, representing mitochondria dividing and binding with one another, decreased axonal transport of mitochondria, a lower percentage of mitochondria within…”
BackgroundAlzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
(1978) · Biochemical Education · doi:10.1016/0307-4412(78)90049-3 · Cited by 5,046
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538 · cited 1×
“The leading hypotheses regarding the etiology of AD revolve around either genetic heritability [13], reduced synthesis of acetylcholine [14], the accumulation of neurotoxic protein plaques of amyloid β peptide (Aβ) [15], and fibrillary tangles of hyperphosphorylated tau-protein [16] or irregular function and dynamics…”
BackgroundThe cholinergic hypothesis of Alzheimer’s disease: A review of progress
Francis, P. T., Palmer, A. M., Snape, M., & Wilcock, G. K. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.2.137 · Cited by 2,198
Role of Genes and Environments for Explaining Alzheimer Disease
Gatz, M., Reynolds, C. A., Fratiglioni, L., Johansson, B., Mortimer, J. A., Berg, S., Fiske, A., & Pedersen, N. L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.2.168 · Cited by 1,798
Oxidative stress and mitochondrial dysfunction in Alzheimer’s disease
Wang, X., Wang, W., Li, L., Perry, G., Lee, H.-G., & Zhu, X. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.10.015 · Cited by 1,357
Mitochondrial proton and electron leaks
Jastroch, M., Divakaruni, A. S., Mookerjee, S., Treberg, J. R., & Brand, M. D. (2010) · Essays in Biochemistry · doi:10.1042/bse0470053 · Cited by 829
The Alzheimer’s disease mitochondrial cascade hypothesis: progress and perspectives
Swerdlow, R. H., Burns, J. M., & Khan, S. M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.09.010 · Cited by 786 · cited 2×
“In 2004, Swerdlow and Khan hypothesized that the regulation over mitochondrial baseline activity is inherent genetically but can be influenced by other factors, and along with this influence, mitochondria may accumulate damage resulting in both the symptoms and neuropathology found in AD [24, 25].”
BackgroundA “mitochondrial cascade hypothesis” for sporadic Alzheimer’s disease
Swerdlow, R. H., & Khan, S. M. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2003.12.045 · Cited by 758
Research works printed but not linked: 2
- Nicholls D, Ferguson S (2013) Bioenergetics, 4th edn. Elsevier
- Esteves AR, Arduino DM (2009) “Mitochondrial metabolism in age-related neurodegenerative disorders: Alzheimer’s and Parkinson’s revisited.” In: Svensson OL (ed.) Mitochondria: structure, functions and dysfunctions
Cited by
Zielonka, J., Joseph, J., Sikora, A., Hardy, M., Ouari, O., Vasquez-Vivar, J., Cheng, G., Lopez, M., & Kalyanaraman, B. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00042 · Cited by 1,683
Mitochondria ROS and mitophagy in acute kidney injury
Su, L., Zhang, J., Gomez, H., Kellum, J. A., & Peng, Z. (2023) · Autophagy · doi:10.1080/15548627.2022.2084862 · Cited by 790
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
Mitochondrial dysfunction in neurodegenerative disorders
Klemmensen, M. M., Borrowman, S. H., Pearce, C., Pyles, B., & Chandra, B. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2023.10.002 · Cited by 396
Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling
Wu, Y., Chen, M., & Jiang, J. (2019) · Mitochondrion · doi:10.1016/j.mito.2019.07.003 · Cited by 385
Metadata
- Authors
- Cadonic, C., Sabbir, M. G., & Albensi, B. C.
- Affiliations
- St. Boniface Hospital (CA)
- Corresponding author
- Cadonic, Chris
- Albensi, Benedict C.
- Venue
- Molecular Neurobiology
- Published
- 2015-11-04
- Volume
- 53
- Issue
- 9
- Pages
- 6078-6090
- ISSN
- 0893-7648 (ISSN-L)
- 1559-1182
- OpenAlex
- W2223865021
- Cited by
- 226
- References
- 43
- Citations by year
- 2026: 14 · 2025: 17 · 2024: 11 · 2023: 23 · 2022: 29 · 2021: 32 · 2020: 28 · 2019: 31 · 2018: 20 · 2017: 15 · 2016: 5
- FWCI
- 1.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Molecular Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Natural Sciences and Engineering Research Council of Canada (CA)
- St.Boniface General Hospital Research Foundation (CA)
- The University of Manitoba (CA)
- The Everett Endowment Fund (CA)
- The Edwards Family Endowment (CA)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- mitochondrial dysfunction, Alzheimer's disease, electron transport chain, oxidative phosphorylation, ATP synthase, mitochondrial bioenergetics, NADH, mitochondrial-targeted therapy, neurodegeneration
- MeSH terms
- Alzheimer Disease, Animals, Electron Transport, Energy Metabolism, Humans, Mitochondria, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mechanisms of Mitochondrial Dysfunction in Alzheimer’s Disease. https://app.cochat.ai/papers/10.1007/s12035-015-9515-5
- The paper
- Cadonic, C., Sabbir, M. G., & Albensi, B. C. (2016). Mechanisms of Mitochondrial Dysfunction in Alzheimer’s Disease. Molecular Neurobiology. https://doi.org/10.1007/s12035-015-9515-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.